Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal TransitionsDoble B.W. · Woodgett J.R.
Samuel Lunenfeld Research Institute, Toronto, Ont., Canada
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Epithelial cells usually exist as sheets of immotile, tightly packed, well-coupled, polarized cells with distinct apical, basal and lateral surfaces. Remarkably, these cells can dramatically alter their morphology to become motile, fibroblast-like mesenchymal cells in a process of epithelial-mesenchymal transition (EMT). This process and the reverse, mesenchymal-epithelial transition, occur repeatedly during normal embryonic development. A phenomenon similar to physiological EMT occurs during the pathophysiological progression of some cancers. Tumours of epithelial origin, as they transform to malignancy, appear to exploit the innate plasticity of epithelial cells, with EMT conferring increased invasiveness and metastatic potential. Key to the maintenance of epithelial cell identity is the expression of E-cadherin, a protein that is required for tight intercellular adhesion along the lateral surfaces of adjacent epithelial cells. Loss of functional E-cadherin is a critical event in EMT. An important regulator of E-cadherin expression is the protein Snail, a zinc-finger transcriptional repressor. Snail contains several consensus sites for the kinase, glycogen synthase kinase-3 (GSK-3), and accumulating evidence indicates that it is a GSK-3 substrate. Phosphorylation of Snail by GSK-3 facilitates its proteasomal degradation. Conversely, inhibition of GSK-3 leads to Snail accumulation, E-cadherin downregulation, and development of EMT in cultured epithelial cells. Several signalling pathways implicated in the progression of EMT, including the Wnt and phosphoinositide 3-kinase pathways, use GSK-3 to mediate their responses. In these pathways, GSK-3’s regulation of other transcriptional effectors like β-catenin works in concert with changes in Snail to orchestrate the EMT process. This review focuses on the emerging role of GSK-3 as a modulator of cell fate and EMT in the contexts of development, in vitro cell culture and cancer.
© 2007 S. Karger AG, Basel
- Ahmed, S., A. Nawshad (2007) Complexity in interpretation of embryonic epithelial-mesenchymal transformation in response to transforming growth factor-β signaling. Cells Tissues Organs 185: 131–145.
- Angerer, L.M., R.C. Angerer (1999) Regulative development of the sea urchin embryo: signalling cascades and morphogen gradients. Semin Cell Dev Biol 10: 327–334.
- Aza-Blanc, P., F.A. Ramirez-Weber, M.P. Laget, C. Schwartz, T.B. Kornberg (1997) Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 89: 1043–1053.
- Bachelder, R.E., S.O. Yoon, C. Franci, A.G. de Herreros, A.M. Mercurio (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168: 29–33.
- Blaschuk, O.W., T.M. Rowlands (2002) Plasma membrane components of adherens junctions. Mol Membr Biol 19: 75–80.
Brabletz, T., A. Jung, S. Spaderna, F. Hlubek, T. Kirchner (2005) Opinion: migrating cancer stem cells – an integrated concept of malignant tumour progression. Nat Rev 5: 744–749.
- Brantjes, H., N. Barker, J. van Es, H. Clevers (2002) TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383: 255–261.
- Cardiff, R.D. (2005) Epithelial to mesenchymal transition tumors: fallacious or Snail’s pace? Clin Cancer Res 11: 8534–8537.
- Cavallaro, U. (2004) N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 5: 1274–1278.
- Cole, A., S. Frame, P. Cohen (2004a) Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J 377: 249–255.
- Cole, A.R., A. Knebel, N.A. Morrice, L.A. Robertson, A.J. Irving, C.N. Connolly, C. Sutherland (2004b) GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J Biol Chem 279: 50176–50180.
- Conacci-Sorrell, M., I. Simcha, T. Ben-Yedidia, J. Blechman, P. Savagner, A. Ben-Ze’ev (2003) Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847–857.
- Cross, D.A., D.R. Alessi, P. Cohen, M. Andjelkovich, B.A. Hemmings (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785–789.
- Dale, T. (2006) Kinase cogs go forward and reverse in the Wnt signaling machine. Nat Struct Mol Biol 13: 9–11.
- Daniels, D.L., W.I. Weis (2005) Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12: 364–371.
- Davidson, G., W. Wu, J. Shen, J. Bilic, U. Fenger, P. Stannek, A. Glinka, C. Niehrs (2005) Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438: 867–872.
- Derycke, L.D., M.E. Bracke (2004) N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 48: 463–476.
- Ding, V.W., R.H. Chen, F. McCormick (2000) Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem 275: 32475–32481.
- Ding, Q., W. Xia, J.C. Liu, J.Y. Yang, D.F. Lee, J. Xia, G. Bartholomeusz, Y. Li, Y. Pan, Z. Li, R.C. Bargou, J. Qin, C.C. Lai, F.J. Tsai, C.H. Tsai, M.C. Hung (2005) Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19: 159–170.
- Doble, B.W., J.R. Woodgett (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175–1186.
- Ferkey, D.M., D. Kimelman (2002) Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin. J Biol Chem 277: 16147–16152.
- Fiol, C.J., A.M. Mahrenholz, Y. Wang, R.W. Roeske, P.J. Roach (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem 262: 14042–14048.
- Foty, R.A., M.S. Steinberg (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48: 397–409.
- Frame, S., P. Cohen (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359: 1–16.
- Franca-Koh, J., M. Yeo, E. Fraser, N. Young, T.C. Dale (2002) The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. J Biol Chem 277: 43844–43848.
- Fraser, E., N. Young, R. Dajani, J. Franca-Koh, J. Ryves, R.S. Williams, M. Yeo, M.T. Webster, C. Richardson, M.J. Smalley, L.H. Pearl, A. Harwood, T.C. Dale (2002) Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J Biol Chem 277: 2176–2185.
- Frodin, M., S. Gammeltoft (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151: 65–77.
- Fuchs, S.Y., V.S. Spiegelman, K.G. Kumar (2004) The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene 23: 2028–2036.
- Fujimuro, M., S.D. Hayward (2003) The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77: 8019–8030.
- Fujimuro, M., F.Y. Wu, C. ApRhys, H. Kajumbula, D.B. Young, G.S. Hayward, S.D. Hayward (2003) A novel viral mechanism for dysregulation of beta-catenin in Kaposi’s sarcoma-associated herpesvirus latency. Nat Med 9: 300–306.
- Greenburg, G., E.D. Hay (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95: 333–339.
- Grego-Bessa, J., J. Diez, L. Timmerman, J.L. de la Pompa (2004) Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 3: 718–721.
- Gumbiner, B.M. (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6: 622–634.
- Ha, N.C., T. Tonozuka, J.L. Stamos, H.J. Choi, W.I. Weis (2004) Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15: 511–521.
- Hay, E.D. (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706–720.
- He, X., M. Semenov, K. Tamai, X. Zeng (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663–1677.
- Hoeflich, K.P., J. Luo, E.A. Rubie, M.S. Tsao, O. Jin, J.R. Woodgett (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86–90.
- Huber, M.A., N. Kraut, H. Beug (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548–558.
- Hurlstone, A., H. Clevers (2002) T-cell factors: turn-ons and turn-offs. EMBO J 21: 2303–2311.
- Ikeda, S., S. Kishida, H. Yamamoto, H. Murai, S. Koyama, A. Kikuchi (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371–1384.
- Ingham, P.W., A.P. McMahon (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059–3087.
- Jamora, C., R. DasGupta, P. Kocieniewski, E. Fuchs (2003) Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422: 317–322.
- Jho, E., S. Lomvardas, F. Costantini (1999) A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Biochem Biophys Res Commun 266: 28–35.
- Jia, J., K. Amanai, G. Wang, J. Tang, B. Wang, J. Jiang (2002) Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus. Nature 416: 548–552.
- Johnson, R.L., E. Laufer, R.D. Riddle, C. Tabin (1994) Ectopic expression of Sonic hedgehog alters dorsal-ventral patterning of somites. Cell 79: 1165–1173.
- Karhadkar, S.S., G.S. Bova, N. Abdallah, S. Dhara, D. Gardner, A. Maitra, J.T. Isaacs, D.M. Berman, P.A. Beachy (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707–712.
- Katanaev, V.L., R. Ponzielli, M. Semeriva, A. Tomlinson (2005) Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120: 111–122.
- Kim, K., Z. Lu, E.D. Hay (2002) Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26: 463–476.
- Kispert, A., S. Vainio, A.P. McMahon (1998) Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 125: 4225–4234.
- Labbe, E., A. Letamendia, L. Attisano (2000) Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97: 8358–8363.
- Larue, L., M. Ohsugi, J. Hirchenhain, R. Kemler (1994) E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 91: 8263–8267.
- Larue, L., A. Bellacosa (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24: 7443–7454.
- Leung, J.Y., F.T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K.R. Cho, E.R. Fearon (2002) Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 277: 21657–21665.
- Liebner, S., A. Cattelino, R. Gallini, N. Rudini, M. Iurlaro, S. Piccolo, E. Dejana (2004) Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166: 359–367.
Lillie, F.R. (1908) The Development of the Chick. New York, Henry Holt.
- Liu, X., J.S. Rubin, A.R. Kimmel (2005) Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 15: 1989–1997.
- Lochhead, P.A., R. Kinstrie, G. Sibbet, T. Rawjee, N. Morrice, V. Cleghon (2006) A chaperone-dependent GSK-3beta transitional intermediate mediates activation-loop autophosphorylation. Mol Cell 24: 627–633.
- Logan, C.Y., R. Nusse (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810.
- Louro, I.D., E.C. Bailey, X. Li, L.S. South, P.R. McKie-Bell, B.K. Yoder, C.C. Huang, M.R. Johnson, A.E. Hill, R.L. Johnson, J.M. Ruppert (2002) Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res 62: 5867–5873.
- Lustig, B., B. Jerchow, M. Sachs, S. Weiler, T. Pietsch, U. Karsten, M. van de Wetering, H. Clevers, P.M. Schlag, W. Birchmeier, J. Behrens (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184–1193.
- Mayor, R., R. Morgan, M.G. Sargent (1995) Induction of the prospective neural crest of Xenopus. Development 121: 767–777.
- McManus, E.J., K. Sakamoto, L.J. Armit, L. Ronaldson, N. Shpiro, R. Marquez, D.R. Alessi (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24: 1571–1583.
- Medici, D., E.D. Hay, D.A. Goodenough (2006) Cooperation between Snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 17: 1871–1879.
- Mi, K., P.J. Dolan, G.V. Johnson (2006) The low-density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. J Biol Chem 281: 4787–4794.
- Mukai, F., K. Ishiguro, Y. Sano, S.C. Fujita (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J Neurochem 81: 1073–1083.
- Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, S. Shimizu (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443.
- Naldini, L., K.M. Weidner, E. Vigna, G. Gaudino, A. Bardelli, C. Ponzetto, R.P. Narsimhan, G. Hartmann, R. Zarnegar, G.K. Michalopoulos, et al. (1991) Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867–2878.
- Nelson, W.J., R. Nusse (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483–1487.
- Nieto, M.A., M.G. Sargent, D.G. Wilkinson, J. Cooke (1994) Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835–839.
- Nieto, M.A. (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155–166.
- Nishita, M., M.K. Hashimoto, S. Ogata, M.N. Laurent, N. Ueno, H. Shibuya, K.W. Cho (2000) Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann’s organizer. Nature 403: 781–785.
- Oloumi, A., T. McPhee, S. Dedhar (2004) Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta 1691: 1–15.
- Orsulic, S., M. Peifer (1996) Cell-cell signalling: Wingless lands at last. Curr Biol 6: 1363–1367.
- Pan, Y., C.B. Bai, A.L. Joyner, B. Wang (2006) Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol 26: 3365–3377.
- Papadopoulou, D., M.W. Bianchi, M. Bourouis (2004) Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster. Mol Cell Biol 24: 4909–4919.
- Peinado, H., F. Portillo, A. Cano (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365–375.
- Price, M.A., D. Kalderon (2002) Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by glycogen synthase kinase 3 and casein kinase 1. Cell 108: 823–835.
- Rubinfeld, B., I. Albert, E. Porfiri, C. Fiol, S. Munemitsu, P. Polakis (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272: 1023–1026.
- Sakai, D., Y. Tanaka, Y. Endo, N. Osumi, H. Okamoto, Y. Wakamatsu (2005) Regulation of Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signaling. Dev Growth Differ 47: 471–482.
- Schaffer, B., M. Wiedau-Pazos, D.H. Geschwind (2003) Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302: 73–81.
- Schweizer, L., H. Varmus (2003) Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Biol 4: 4.
- Stambolic, V., J.R. Woodgett (1994) Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303: 701–704.
- Stark, K., S. Vainio, G. Vassileva, A.P. McMahon (1994) Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679–683.
- Stoker, M., M. Perryman (1985) An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209–223.
- Sutherland, C., I.A. Leighton, P. Cohen (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296: 15–19.
- Tamai, K., M. Semenov, Y. Kato, R. Spokony, C. Liu, Y. Katsuyama, F. Hess, J.P. Saint-Jeannet, X. He (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530–535.
- Tarin, D., E.W. Thompson, D.F. Newgreen (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 5996–6000; discussion 6000–6001.
- Tempe, D., M. Casas, S. Karaz, M.F. Blanchet-Tournier, J.P. Concordet (2006) Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol 26: 4316–4326.
- Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442–454.
- Thomas, G.M., S. Frame, M. Goedert, I. Nathke, P. Polakis, P. Cohen (1999) A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett 458: 247–251.
- Timmerman, L.A., J. Grego-Bessa, A. Raya, E. Bertran, J.M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J.C. Izpisua-Belmonte, J.L. de la Pompa (2004) Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18: 99–115.
- Vallin, J., R. Thuret, E. Giacomello, M.M. Faraldo, J.P. Thiery, F. Broders (2001) Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 276: 30350–30358.
- van Amerongen, R., A. Berns (2005) Re-evaluating the role of Frat in Wnt-signal transduction. Cell Cycle 4: 1065–1072.
- van Amerongen, R., M. Nawijn, J. Franca-Koh, J. Zevenhoven, H. van der Gulden, J. Jonkers, A. Berns (2005) Frat is dispensable for canonical Wnt signaling in mammals. Genes Dev 19: 425–430.
- Wehrli, M., S.T. Dougan, K. Caldwell, L. O’Keefe, S. Schwartz, D. Vaizel-Ohayon, E. Schejter, A. Tomlinson, S. DiNardo (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527–530.
- Wheelock, M.J., K.R. Johnson (2003) Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19: 207–235.
- Woodgett, J.R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9: 2431–2438.
Woodgett, J.R. (2001) Judging a protein by more than its name: GSK-3. Sci STKE 2001: RE12.
- Woodgett, J.R. (2005) Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17: 150–157.
- Yamamoto, H., S. Kishida, M. Kishida, S. Ikeda, S. Takada, A. Kikuchi (1999) Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274: 10681–10684.
- Yang, J., S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, R.A. Weinberg (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.
- Yook, J.I., X.Y. Li, I. Ota, E.R. Fearon, S.J. Weiss (2005) Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 280: 11740–11748.
- Yook, J.I., X.Y. Li, I. Ota, C. Hu, H.S. Kim, N.H. Kim, S.Y. Cha, J.K. Ryu, Y.J. Choi, J. Kim, E.R. Fearon, S.J. Weiss (2006) A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8: 1398–1406.
- Yuan, H., J. Mao, L. Li, D. Wu (1999) Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J Biol Chem 274: 30419–30423.
- Zavadil, J., L. Cermak, N. Soto-Nieves, E.P. Bottinger (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23: 1155–1165.
- Zavadil, J., E.P. Bottinger (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764–5774.
- Zavadil, J., M. Narasimhan, M. Blumenberg, R.J. Schneider (2007) Transforming growth factor-β and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185: 157–161.
- Zeng, X., K. Tamai, B. Doble, S. Li, H. Huang, R. Habas, H. Okamura, J. Woodgett, X. He (2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873–877.
- Zhou, B.P., J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, M.C. Hung (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931–940.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.